Adrienne H Baughman

发表

Comparison of clinical prediction models for resistant bacteria in community-onset pneumonia.

W. Self, R. Wunderink, Carlos G. Grijalva, 2015, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

Seroprevalence of SARS-CoV-2 Among Frontline Healthcare Personnel During the First Month of Caring for Patients With COVID-19—Nashville, Tennessee

Manish M Patel, W. Self, T. Rice, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Influenza Vaccine Effectiveness for Prevention of Severe Influenza-Associated Illness among Adults in the United States, 2019-2020: A test-negative study.

Samuel M. Brown, Manish M Patel, M. Exline, 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study

M. Exline, Akram Khan, W. Self, 2022, BMJ.

Comparative Effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) Vaccines in Preventing COVID-19 Hospitalizations Among Adults Without Immunocompromising Conditions — United States, March–August 2021

David W. McDonald, Meghan A. Wallace, Joel D. Levitt, 2021, MMWR. Morbidity and mortality weekly report.

Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Among Hospitalized Adults Aged ≥65 Years — United States, January–March 2021

Samuel M. Brown, Manish M Patel, M. Exline, 2021, MMWR. Morbidity and mortality weekly report.

Protection of mRNA vaccines against hospitalized COVID-19 in adults over the first year following authorization in the United States

M. Exline, Akram Khan, W. Self, 2022, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Sustained Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Associated Hospitalizations Among Adults — United States, March–July 2021

David W. McDonald, Meghan A. Wallace, Joel D. Levitt, 2021, MMWR. Morbidity and mortality weekly report.

mRNA Vaccine Effectiveness Against Coronavirus Disease 2019 Hospitalization Among Solid Organ Transplant Recipients

M. Exline, Akram Khan, W. Self, 2022, The Journal of infectious diseases.

Effectiveness of mRNA Vaccination in Preventing COVID-19–Associated Invasive Mechanical Ventilation and Death — United States, March 2021–January 2022

M. Exline, Akram Khan, W. Self, 2022, MMWR. Morbidity and mortality weekly report.

Effectiveness of a Third Dose of Pfizer-BioNTech and Moderna Vaccines in Preventing COVID-19 Hospitalization Among Immunocompetent and Immunocompromised Adults — United States, August–December 2021

Manish M Patel, M. Exline, Akram Khan, 2022, MMWR. Morbidity and mortality weekly report.

Bivalent mRNA vaccine improves antibody-mediated neutralization of many SARS-CoV-2 Omicron lineage variants

W. Self, D. Hager, N. Shapiro, 2023, bioRxiv.

Effectiveness of SARS-CoV-2 mRNA Vaccines for Preventing Covid-19 Hospitalizations in the United States

Samuel M. Brown, Manish M Patel, H. Gershengorn, 2021, medRxiv.

Effect of Early High-Dose Vitamin D3 Repletion on Cognitive Outcomes in Critically Ill Adults.

Mayur B. Patel, Samuel M. Brown, Akram Khan, 2021, Chest.

Association Between mRNA Vaccination and COVID-19 Hospitalization and Disease Severity.

M. Exline, Akram Khan, W. Self, 2021, JAMA.

Early urine electrolyte patterns in patients with acute heart failure

W. Self, C. McNaughton, A. Storrow, 2018, ESC Heart Failure.

Ascertainment of vaccination status by self‐report versus source documentation: Impact on measuring COVID‐19 vaccine effectiveness

M. Exline, W. Self, A. Ginde, 2022, Influenza and other respiratory viruses.

Effectiveness of SARS-CoV-2 mRNA Vaccines for Preventing Covid-19 Hospitalizations in the United States

Samuel M. Brown, Manish M Patel, H. Gershengorn, 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19–Associated Hospitalization Among Immunocompetent Adults Aged ≥65 Years — IVY Network, 18 States, September 8–November 30, 2022

M. Exline, Akram Khan, W. Self, 2022, MMWR. Morbidity and mortality weekly report.

Effectiveness of Severe Acute Respiratory Syndrome Coronavirus 2 Messenger RNA Vaccines for Preventing Coronavirus Disease 2019 Hospitalizations in the United States

Manish M Patel, H. Gershengorn, M. Exline, 2021, Clinical Infectious Diseases.

Effectiveness of Monovalent mRNA Vaccines Against COVID-19-Associated Hospitalization Among Immunocompetent Adults During BA.1/BA.2 and BA.4/BA.5 Predominant Periods of SARS-CoV-2 Omicron Variant in the United States - IVY Network, 18 States, December 26, 2021-August 31, 2022.

M. Exline, Akram Khan, W. Self, 2022, MMWR. Morbidity and mortality weekly report.

Modeling the impacts of clinical influenza testing on influenza vaccine effectiveness estimates.

Samuel M. Brown, Manish M Patel, M. Exline, 2021, The Journal of infectious diseases.

Incorporating real-time influenza detection into the test-negative design for estimating influenza vaccine effectiveness: The real-time test-negative design (rtTND).

Samuel M. Brown, Manish M Patel, M. Exline, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Effectiveness of Monovalent mRNA COVID-19 Vaccination in Preventing COVID-19-Associated Invasive Mechanical Ventilation and Death Among Immunocompetent Adults During the Omicron Variant Period - IVY Network, 19 U.S. States, February 1, 2022-January 31, 2023.

M. Exline, Akram Khan, W. Self, 2023, MMWR. Morbidity and mortality weekly report.

Absolute and Relative Vaccine Effectiveness of Primary and Booster Series of COVID-19 Vaccines (mRNA and Adenovirus Vector) Against COVID-19 Hospitalizations in the United States, December 2021–April 2022

M. Exline, Akram Khan, W. Self, 2022, Open forum infectious diseases.

Comparison of test-negative and syndrome-negative controls in SARS-CoV-2 vaccine effectiveness evaluations for preventing COVID-19 hospitalizations in the United States

M. Exline, Akram Khan, W. Self, 2022, Vaccine.

Comparison of mRNA vaccine effectiveness against COVID-19-associated hospitalization by vaccination source: Immunization information systems, electronic medical records, and self-report—IVY Network, February 1–August 31, 2022

Akram Khan, W. Self, A. Ginde, 2023, Vaccine.